NAD, MOTS-c, and SS-31: Mitochondrial Research Product Comparison

Mitochondrial Research | 2026-09-13 | 13 min read

A mitochondrial research sourcing guide comparing NAD, MOTS-c, and SS-31 by identity, research scope, COA, format, price basis, and supplier documentation.

One search cluster can contain different material types

NAD, MOTS-c, and SS-31 often appear together in mitochondrial and longevity research searches. They should not be treated as one product family for purchasing. NAD is a dinucleotide cofactor, while MOTS-c and SS-31 are peptide research materials with different identities and analytical questions.

For a laboratory buyer, the first task is to separate the material type, exact product identity, chemical form, product code, strength, and intended assay. A broad term such as mitochondrial peptide is useful for discovery but is too vague for a purchase order.

Identity and format differences

NAD-related products may be listed by chemical form and purity basis. MOTS-c and SS-31 should be specified by peptide identity, sequence or modification, strength, vial count, and net quantity basis. A buyer should preserve these distinctions in the catalog and inventory system.

When comparing price, do not combine a mass-based small molecule quote with a milligram peptide quote without documenting the unit and total amount. For a blend or formulation, list the components and final composition separately.

COA review across the three categories

The analytical package should match the material. For a peptide, buyers may review HPLC purity, molecular-mass identity, water, counterion, and residual solvent. For NAD or another nucleotide-related compound, the method and assay basis may be different. The same COA template should not be assumed to fit every material.

Ask whether the document is batch-specific, whether the product code matches the label, and whether the reported result is purity, assay, net content, or another measurement. Keep the method name and reporting units with the result.

Research scope and evidence boundaries

MOTS-c and SS-31 are discussed in cellular, animal, and translational research. NAD-related work spans cellular metabolism, redox biology, and cofactor systems. These research areas do not turn catalog material into an approved therapy. A responsible article should describe the model and evidence level rather than make broad human-use promises.

A procurement comparison table

For each item, record exact identity, material type, product code, strength or assay basis, package size, COA fields, storage, price, shipping, and lead time. Then add a project-fit note: cell assay, analytical reference, formulation study, stability study, or another approved laboratory purpose.

For recurring orders, retain batch history and document any change in chemical form, counterion, packaging, analytical method, or supplier code. This protects comparability across a long research program.

Supplier questions

• Is NAD separated from peptide products in the quotation?
• Are MOTS-c and SS-31 specified by exact identity and format?
• Does the COA state the measured attribute and method?
• Is the result linked to the quoted batch?
• Are price units and total quantities comparable?
• Are storage and research-use terms clear?

ZePeptide supports mitochondrial research catalog review, product specification comparison, COA coordination, and B2B quotation requests. This content is for lawful laboratory research and does not provide personal-use or treatment instructions.

ZePeptide content is for lawful laboratory and in-vitro research sourcing. Products are not supplied for human or veterinary use.